Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistency

Stephen F. Kry; Jessica Lye; Catharine H. Clark; Nicolaus Andratschke; Alexis Dimitriadis; D Followill; Rebecca M. Howell; Mohammad Hussein; Masayori Ishikawa; Satoshi Kito; Tomas Kron; Jonny Lee; Jeff M. Michalski; A.F. Monti; N. Reynaert; Paige A. Taylor; Karen Venables; Ying Xiao; Jöerg Lehmann

doi:10.1016/j.radonc.2021.03.006

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Dose to medium in medium (Dm,m) is the preferred dose calculation and reporting framework. If an institution's planning system can only calculate dose to water in water (Dw,w), this is acceptable.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kry et al. (2021) studied this question.

synapsesocial.com/papers/69dbdc6ef7e0c66ced836955 https://doi.org/10.1016/j.radonc.2021.03.006

View Full Paper

Ask AI

Bookmark

Share

Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistency

Ask about this paper

Abstract

Discussion

Cite This Study

Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistency

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading